| - GRCh37:
- Chr17:39740660
- GRCh38:
- Chr17:41584408
| KRT14 | E205fs | Epidermolysis bullosa simplex 1A, generalized severe | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr17:39742899
- GRCh38:
- Chr17:41586647
| KRT14 | C63Y | Naegeli-Franceschetti-Jadassohn syndrome, Epidermolysis bullosa simplex 1A, generalized severe, Dermatopathia pigmentosa reticularis, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1C, localized, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52913552
- GRCh38:
- Chr12:52519768
| KRT5 | N177Y | Epidermolysis bullosa simplex 1A, generalized severe | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:39739502-39739519
- GRCh38:
- Chr17:41583250-41583267
| KRT14 | | Epidermolysis bullosa simplex 1A, generalized severe | Pathogenic (Nov 9, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:39742921
- GRCh38:
- Chr17:41586669
| KRT14 | R56C | Epidermolysis bullosa simplex 1A, generalized severe, Dermatopathia pigmentosa reticularis, Naegeli-Franceschetti-Jadassohn syndrome, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1C, localized, not provided | Benign/Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52913971
- GRCh38:
- Chr12:52520187
| KRT5 | R37Q | Dowling-Degos disease 1, Epidermolysis bullosa simplex with migratory circinate erythema, Epidermolysis bullosa simplex with mottled pigmentation, Epidermolysis bullosa simplex 1A, generalized severe, Epidermolysis bullosa simplex 2A, generalized severe, Epidermolysis bullosa simplex 2B, generalized intermediate, Epidermolysis bullosa simplex 2C, localized, Epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive, Epidermolysis bullosa simplex, not provided | Benign/Likely benign (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39742718
- GRCh38:
- Chr17:41586466
| KRT14 | | not specified, Dermatopathia pigmentosa reticularis, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, Naegeli-Franceschetti-Jadassohn syndrome, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex 1A, generalized severe, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39742894
- GRCh38:
- Chr17:41586642
| KRT14 | | Dermatopathia pigmentosa reticularis, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, Naegeli-Franceschetti-Jadassohn syndrome, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex 1A, generalized severe, not specified, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39742898
- GRCh38:
- Chr17:41586646
| KRT14 | | Dermatopathia pigmentosa reticularis, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, Naegeli-Franceschetti-Jadassohn syndrome, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex 1A, generalized severe, not specified, not provided | Benign (Aug 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39739515
- GRCh38:
- Chr17:41583263
| KRT14 | R416fs | Epidermolysis bullosa simplex 1A, generalized severe | Pathogenic (Nov 11, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:39739524
- GRCh38:
- Chr17:41583272
| KRT14 | A413T | Dermatopathia pigmentosa reticularis, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, Naegeli-Franceschetti-Jadassohn syndrome, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex 1A, generalized severe, not provided | Benign/Likely benign (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39739575
- GRCh38:
- Chr17:41583323
| KRT14 | Q396* | Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex 1A, generalized severe, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive
| Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr12:52912906
- GRCh38:
- Chr12:52519122
| KRT5, LOC126861526 | | not specified, not provided, Epidermolysis bullosa simplex, Epidermolysis bullosa simplex 2A, generalized severe, Epidermolysis bullosa simplex 2B, generalized intermediate, Epidermolysis bullosa simplex 2C, localized, Epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive, Epidermolysis bullosa simplex 1A, generalized severe, Dowling-Degos disease 1, Epidermolysis bullosa simplex with migratory circinate erythema, Epidermolysis bullosa simplex with mottled pigmentation ...see more | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52912921
- GRCh38:
- Chr12:52519137
| LOC126861526, KRT5 | N193K | Epidermolysis bullosa simplex 1A, generalized severe | Likely pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52910433
- GRCh38:
- Chr12:52516649
| KRT5, LOC126861525 | G476D | Epidermolysis bullosa simplex 1A, generalized severe, not provided | Pathogenic (Feb 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52910431
- GRCh38:
- Chr12:52516647
| KRT5, LOC126861525 | E477K | Epidermolysis bullosa simplex, Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex with mottled pigmentation
| Pathogenic (May 28, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52913540
- GRCh38:
- Chr12:52519756
| KRT5 | S181P | Epidermolysis bullosa simplex 1A, generalized severe | Pathogenic (Feb 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr12:52911486
- GRCh38:
- Chr12:52517702
| KRT5 | M327T | Dowling-Degos disease 1, Epidermolysis bullosa simplex 1C, localized, Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex with migratory circinate erythema, Epidermolysis bullosa simplex with mottled pigmentation, Epidermolysis bullosa simplex 1A, generalized severe, Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive, not provided, Epidermolysis bullosa simplex, Koebner type
| Pathogenic (Nov 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39742719
- GRCh38:
- Chr17:41586467
| KRT14 | N123S | not provided | Pathogenic (Oct 18, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:39739505
- GRCh38:
- Chr17:41583253
| KRT14 | L419Q | Epidermolysis bullosa simplex 1A, generalized severe | Pathogenic (Oct 28, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:39742731
- GRCh38:
- Chr17:41586479
| KRT14 | M119T | not provided | Pathogenic (Dec 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:39742713
- GRCh38:
- Chr17:41586461
| KRT14 | R125H | KRT14-related condition, not provided, Dermatopathia pigmentosa reticularis
| Pathogenic (Dec 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39742714
- GRCh38:
- Chr17:41586462
| KRT14 | R125C | Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1A, generalized severe, not provided, Epidermolysis bullosa simplex, Epidermolysis bullosa simplex, Koebner type | Pathogenic (Sep 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:39739610
- GRCh38:
- Chr17:41583358
| KRT14 | L384P | Epidermolysis bullosa simplex, Koebner type, Epidermolysis bullosa simplex 1A, generalized severe | Pathogenic/Likely pathogenic (Oct 30, 2023) | no assertion criteria provided |